Clinical Randomisation of an Antifibrinolytic in Significant Head Injury

NCT01402882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12737

Enrollment

OTHER

Sponsor class

Conditions

Traumatic Brain Injury

Interventions

DRUG: Tranexamic Acid

Sponsor

London School of Hygiene and Tropical Medicine